Vertex Pharmaceuticals, Inc. (VRTX)

440.09 -1.27 (-0.29%) USD  |  NASDAQ  |  Jan 20, 12:20
More

Vertex Pharmaceuticals Normalized Income (Quarterly)

Normalized Income (Quarterly) Chart

View Normalized Income (Quarterly) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Income (Quarterly) Range, Past 5 Years

View Normalized Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Income (Quarterly) Benchmarks

View Normalized Income (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade